LLY - Point Biopharma quickly gains as big holder comes out against Eli Lilly deal
2023-11-06 14:00:35 ET
More on POINT Biopharma Global
- Eli Lilly POINTs Toward Radiopharmaceutical Ambitions
- POINT Biopharma trades through deal price with Eli Lilly
- Eli Lilly to acquire Point Biopharma in $1.4B deal (update)
- Seeking Alpha’s Quant Rating on POINT Biopharma Global
- Historical earnings data for POINT Biopharma Global
For further details see:
Point Biopharma quickly gains as big holder comes out against Eli Lilly deal